Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world

J Hepatol. 2021 Jul;75(1):224-226. doi: 10.1016/j.jhep.2021.03.009. Epub 2021 Mar 20.

¹ Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital. Clinical and Translational Digestive Research Group, IDIVAL. Santander, Spain; School of Medicine, University of Cantabria. Santander, Spain. Electronic address: javier.crespo@scsalud.es.
² Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona. Barcelona, Spain.
³ Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital. Clinical and Translational Digestive Research Group, IDIVAL. Santander, Spain.
⁴ Microbiology Service, San Cecilio University Hospital. Instituto de Investigación Ibs. Granada, Spain.
⁵ Liver Unit, La Paz University Hospital. CIBERehd. IdiPAZ. Madrid, Spain.

No abstract available

Keywords: COVID-19; SARS-CoV2 vaccination; Viral hepatitis elimination; hepatitis C screening.

Publication types